23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
In February 2020, the IRS issued Notice 2020-12, which provides long-awaited guidance on when a “qu...
Read More >
A local air district is developing a rule that would require both existing and proposed warehouses t...
Read More >
Corporate M&A activity burned white hot last year, reaching record highs of $1.74 trillion in value ...
Read More >
The recent case of PBS Energo A.S v Bester Generacion UK Ltd [2020] EWHC 223 (TCC) provides a remind...
Read More >
Seminole County has commissioned a study to replace the county's road impact fee with a mobility fee...
Read More >
Many California laws seek to restrict the terms and conditions an employer may place on an employee ...
Read More >